Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer (ECKINOXE)
PRODIGE 22-ECKINOXE : Randomized Phase II Trial of Neoadjuvant FOLFOX 4 Versus FOLFOX 4 With Cetuximab Versus Immediate Surgery in Locally Advanced Colon Cancer
Sponsor: Assistance Publique - Hôpitaux de Paris
A PHASE2 clinical study on Colon Cancer and Locally Advanced Malignant Neoplasm, this trial is ongoing. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 7 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
May 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Association Européenne de Recherche en Oncologie
- Association de Recherche Experimentale et Clinique en Chirurgie Digestive
- Federation Francophone de Cancerologie Digestive
- Merck Serono S.A., Geneva
- UNICANCER
For direct contact, visit the study record on ClinicalTrials.gov .